↓ Skip to main content

Attributable healthcare utilization and cost of pneumoniae due to drug-resistant Streptococcus pneumoniae: a cost analysis

Overview of attention for article published in Antimicrobial Resistance & Infection Control, May 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

blogs
2 blogs
twitter
11 X users

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
87 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Attributable healthcare utilization and cost of pneumoniae due to drug-resistant Streptococcus pneumoniae: a cost analysis
Published in
Antimicrobial Resistance & Infection Control, May 2014
DOI 10.1186/2047-2994-3-16
Pubmed ID
Authors

Courtney A Reynolds, Jonathan A Finkelstein, G Thomas Ray, Matthew R Moore, Susan S Huang

Abstract

The burden of disease due to S. pneumoniae (pneumococcus), particularly pneumonia, remains high despite the widespread use of vaccines. Drug resistant strains complicate clinical treatment and may increase costs. We estimated the annual burden and incremental costs attributable to antibiotic resistance in pneumococcal pneumonia.

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 87 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 1%
Unknown 86 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 13 15%
Student > Master 12 14%
Researcher 11 13%
Student > Doctoral Student 9 10%
Student > Bachelor 9 10%
Other 14 16%
Unknown 19 22%
Readers by discipline Count As %
Medicine and Dentistry 24 28%
Agricultural and Biological Sciences 14 16%
Biochemistry, Genetics and Molecular Biology 7 8%
Immunology and Microbiology 6 7%
Economics, Econometrics and Finance 3 3%
Other 14 16%
Unknown 19 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 May 2014.
All research outputs
#1,945,687
of 25,734,859 outputs
Outputs from Antimicrobial Resistance & Infection Control
#202
of 1,478 outputs
Outputs of similar age
#18,819
of 240,768 outputs
Outputs of similar age from Antimicrobial Resistance & Infection Control
#2
of 11 outputs
Altmetric has tracked 25,734,859 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,478 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.7. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 240,768 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.